RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Former Goldman Sachs Exec on Ethereum: ‘This Is the Fastest Growing Economy on Earth’
  2. Dorsey Challenges Cook: 'Why No Bitcoin in Apple Pay?'
  3. State Street Corp. Adds 10% On Additional Share Repurchase
  4. Bitcoin: A ‘Lottery Ticket’? Ireland’s Central Bank Governor Weighs In on Crypto
  5. Crawling Now, Sprinting Later: Analyst Foresees Major Bitcoin Rally